Allanore Y, Khanna D, Smith V, Aringer M, Hoffmann-Vold AM, Kuwana M, Merkel PA, Stock C, Sambevski S, Denton CP, SENSCIS trial investigators(2023) Effects of nintedanib in patients with limited cutaneous systemic sclerosis and interstitial lung disease Rheumatology (Oxford)(in press) DOI 10.1093/rheumatology/kead280, PubMed 37294870
Boleto G, Reiseter S, Hoffmann-Vold AM, Mirouse A, Cacoub P, Matucci-Cerinic M, Silvério-António M, Fonseca JE, Duarte AC, Pestana Lopes J, Riccieri V, Lescoat A, Le Tallec E, Castellví Barranco I, Tandaipan JL, Airó P, Kuwana M, Kavosi H, Avouac J, Allanore Y(2023) The phenotype of mixed connective tissue disease patients having associated interstitial lung disease Semin Arthritis Rheum, 63, 152258(in press) DOI 10.1016/j.semarthrit.2023.152258, PubMed 37696231
Campochiaro C, Hoffmann-Vold AM, Avouac J, Henes J, de Vries-Bouwstra J, Smith V, Siegert E, Airò P, Oksel F, Pellerito R, Vanthuyne M, Pozzi MR, Inanc M, Sibilia J, Gabrielli A, Distler O, Allanore Y, EUSTAR Collaborators(2023) Sex influence on outcomes of patients with systemic sclerosis-associated interstitial lung disease: a EUSTAR database analysis Rheumatology (Oxford), 62(7), 2483-2491 DOI 10.1093/rheumatology/keac660, PubMed 36413079
